SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CEPH
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
998 24 0 CEPH
Emcee:  Stephanie Mocilan Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
373 Steve, I disagree ( would you expect anything else from me?). The advisory comWeirdPro Randy-5/28/1997
372 It was a bone head play...no 2 ways about it! It was an outright bet that Myo IN_GOD_I_TRUST-5/28/1997
371 Steve, kind of thought I might get dinged on that comment. The options purchasWeirdPro Randy-5/28/1997
370 "Prior to the Advisory board, they didn't make a "comment" eIN_GOD_I_TRUST-5/27/1997
369 FDA has until Aug. 11 to make decision on myotrophin application, Europe will pWeirdPro Randy-5/26/1997
368 Cephalon has major players handing them R&D Money. In the eyes of Chiron, TRobert M. Dunne-5/25/1997
367 when will you learn your lesson? zero for two, but the fda will approve it. The Dermatologist-5/25/1997
366 I have just recently coverd my short and have now have placed an AUG Call, shouRobert M. Dunne-5/24/1997
365 Agreed. Its a waiting game now ... SteveIN_GOD_I_TRUST-5/24/1997
364 We have already hit the lull, very low volume and narrow trading range for the WeirdPro Randy-5/24/1997
363 We hit the high I had thought. Now we go into the lull while we wait. Lets seeIN_GOD_I_TRUST-5/23/1997
362 Have you looked into Cytogen (CYTO) a $5.00 stock with three recent FDA approvaharkenman-5/22/1997
361 bye-byeThe Dermatologist-5/21/1997
360 I may be very bullish on CEPH, but it is the street or the market makers who arWeirdPro Randy-5/20/1997
359 They voted against recommending approval. But the FDA saw it differently. HopeKurtVedder-5/19/1997
358 Only time will tell on this one. Enough said, we're beating this to death.Rocketman-5/18/1997
357 Rman, I got CEPH info packet. It includes a 1/96 NeuroInvestment Newsletter. Atsquetch-5/18/1997
356 Randy, I am completely on your side. If FDA wont to stand as independent goveMiljenko Zuanic-5/17/1997
355 Rocketman, you are correct that the FDA does choose to go up against their adviWeirdPro Randy-5/17/1997
354 Actually, while you are correct regarding Rescriptor, your conclusion regardingNeuroInvestment-5/17/1997
353 WRONG, the FDA does go against their advisory boards on occasion. Like recentlRocketman-5/17/1997
352 10% market penetration is not uncommon. Plus, not everyone with a disease paysRocketman-5/17/1997
351 "Cephalon may hit $35, but you'll never see $5. In fact it may hit it The Dermatologist-5/16/1997
350 i think you are in stage two of kubler-ross. first stage: denial second stage:The Dermatologist-5/16/1997
349 In your most recent reply you ask ( regarding the advisory board meeting) <WeirdPro Randy-5/16/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News